AFP — AFT Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$389.31m
- AU$423.75m
- NZ$254.71m
Australia Stock Exchange release from AFT PHARM : FY2021 Announcement
Australia Stock Exchange release from AFT PHARM : PRE_NR Ends: 07:41:25
Australia Stock Exchange release from AFT PHARM : Appendix 2A
Australia Stock Exchange release from AFT PHARM : AFT extends Maxigesic IV license in South America
Australia Stock Exchange release from AFT PHARM : AFT Pharmaceuticals to announce full year results on Monday
Australia Stock Exchange release from AFT PHARM : Capital change notice - issue of shares
Australia Stock Exchange release from AFT PHARM : PRE_NR Ends: 07:41:47
Australia Stock Exchange release from AFT PHARM : AFT licenses Maxigesic IV in the US
Australia Stock Exchange release from AFT PHARM : Crystawash Extend distribution in UAE, Kuwait, Oman and Ken
Australia Stock Exchange release from AFT PHARM : AFT secures new partners in Poland and Greece
Australia Stock Exchange release from AFT PHARM : AFT updates earnings guidance
Australia Stock Exchange release from AFT PHARM : PRE_NR Ends: 07:41:55
Australia Stock Exchange release from AFT PHARM : AFT licenses Pascomer for Europe
Australia Stock Exchange release from AFT PHARM : PRE_NR Ends: 07:42:33
Australia Stock Exchange release from AFT PHARM : MAXIGESIC IV LICENSED IN EIGHT NEW EUROPEAN MARKETS
Australia Stock Exchange release from AFT PHARM : 24-hour efficacy for Crystawash Extend Hand Sanitiser
Australia Stock Exchange release from AFT PHARM : AFP builds North American momentum
Australia Stock Exchange release from AFT PHARM : AFP determination of Anita Baldauf independence
Australia Stock Exchange release from AFT PHARM : issue of shares